Axsome Therapeutics (AXSM) Gains from Investment Securities (2022 - 2025)
Historic Gains from Investment Securities for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $300000.0.
- Axsome Therapeutics' Gains from Investment Securities changed 0.0% to $300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 3095.6%. This contributed to the annual value of $8.4 million for FY2024, which is 27.38% down from last year.
- Axsome Therapeutics' Gains from Investment Securities amounted to $300000.0 in Q3 2025, which was down 0.0% from $300000.0 recorded in Q2 2025.
- In the past 5 years, Axsome Therapeutics' Gains from Investment Securities ranged from a high of $9.2 million in Q1 2024 and a low of $38000.0 during Q4 2023
- Its 4-year average for Gains from Investment Securities is $4.3 million, with a median of $6.2 million in 2022.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 112368.42% in 2024, then tumbled by 9664.38% in 2025.
- Over the past 4 years, Axsome Therapeutics' Gains from Investment Securities (Quarter) stood at $739000.0 in 2022, then plummeted by 94.86% to $38000.0 in 2023, then soared by 1123.68% to $465000.0 in 2024, then plummeted by 35.48% to $300000.0 in 2025.
- Its Gains from Investment Securities stands at $300000.0 for Q3 2025, versus $300000.0 for Q2 2025 and $8.3 million for Q1 2025.